Difference between revisions of "Brio™ Rechargeable IPG"
Jump to navigation
Jump to search
(infobox) |
(a link added) |
||
| Line 64: | Line 64: | ||
== Ethical & Health Issues == | == Ethical & Health Issues == | ||
<!-- Provide detailed information (if possible or if available) about any ethical risks and related ethical topics, and also related health issues, be it already discovered and covered in literature, or just speculative ones, should be described and properly cited in this section. --> | <!-- Provide detailed information (if possible or if available) about any ethical risks and related ethical topics, and also related health issues, be it already discovered and covered in literature, or just speculative ones, should be described and properly cited in this section. --> | ||
| − | + | http://onlinelibrary.wiley.com/doi/10.1111/ner.12026/full | |
== Public & Media Impact and Presentation == | == Public & Media Impact and Presentation == | ||
<!-- Provide information about the impact the technology had on the public and how the technology is presented in the media or literature. If there was anything in the news regarding this technology, it should be noted and properly cited here. --> | <!-- Provide information about the impact the technology had on the public and how the technology is presented in the media or literature. If there was anything in the news regarding this technology, it should be noted and properly cited here. --> | ||
Revision as of 09:38, 6 April 2017
| Brio™ Rechargeable IPG | |
|---|---|
| [[File:|250px]] | |
| Category | Deep brain stimulation |
| Developer | St. Jude Medical [1] |
| Announced | 2009 [1] |
| Released | Developers:
Consumers: 2009 [1] |
| Price | USD |
| Max output | 12.512.5 T 12.5 mA 0.0125 A [2] |
| Session duration | |
| Scalp location | subthalamic nucleus [3] |
| Weight | 29 g [1] |
| Controls |
N/A |
| Data available | |
| Risk factor | |
| Medical prescription | |
http://www.medicalnewstoday.com/articles/295376.php?trendmd-shared=0
http://www.businesswire.com/news/home/20090909005095/en/St.-Jude-Medical-Receives-CE-Mark-Approval
Contents
Main characteristics
Purpose
Company & People
Important Dates
Enhancement/Therapy/Treatment
Ethical & Health Issues
http://onlinelibrary.wiley.com/doi/10.1111/ner.12026/full
Public & Media Impact and Presentation
Public Policy
Related Technologies, Projects or Scientific Research
References
- ↑ 1.0 1.1 1.2 1.3 St. Jude Medical. St. Jude Medical Receives CE Mark Approval for World’s Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson’s Disease. Newswise, Inc [online]. 2009, Sep 9. Available online at: http://www.newswise.com/articles/st-jude-medical-receives-ce-mark-approval-for-world-s-smallest-longest-lasting-rechargeable-deep-brain-stimulator-for-parkinson-s-disease-first-patient-implanted-with-brio-neurostimulator-at-university-of-cologne-germany32(Retrieved 6th April, 2017).
- ↑ TODO
- ↑ OKUN, M. et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. The Lancet Neurology, 2012, 11(2), 140-149. Available online at: http://www.sciencedirect.com/science/article/pii/S1474442211703088 (Retrieved 6th April, 2017).
